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Background
We have generated genomic and proteomic profiling to
approach cellular and molecular mechanism and to dis-
cover diagnostic and predictive biomarkers of gastric and
colorectal cancer. Based on these gene expression profiles,
we explored the characteristics of molecular changes and
its potential for clinical significances.
Materials and methods
As our present data and systemic analyses for gene expres-
sion pattern, pathway distribution, gene function category,
biosignature and clinical significance shown, we have been
able to document the entire gene expression profiles for
intestinal- and diffuse-type gastric cancer (GC) and normal
appearing tissues (NATs) matched tumors. A group of
specific or typical genes were identified as having dramatic
changes in tumors and NATs compared with the verified
normal samples. Among these genes, at least three gene
sets were analyzed using pathway analysis tools and inte-
grated with biological assay data to construct a network
for GC carcinogenesis.
Results
Our data show that these genes are involved in several
well-studied signaling pathways associated with develop-
ment and progression of GC. Our results indicated that
alterations of MMP11, MT2A, p42.3, Cyr61 and GKN1 at
mRNA and protein level were consistently detected in GC
cell lines and primary tumors compared with matched
normal tissues. Importantly, serum MMP11 levels were
also significantly elevated in GC patients compared with
those of the control subjects, and the positive expression
was well correlated with metastasis and recurrence in GC
patients. As its pilot study, we have generated primary
data of its genomic alterations, in combination and com-
parison with the gene expression profiles. Dramatic corre-
lations have been observed between the gene expression
profiles and DNA Copy Number Variations (CNVs), with
statistically significant differences between tumors of
Stages I-II and III-IV GC. We have also defined a group of
specific gene or miRNA alterations, which could be asso-
ciated with metastasis and recurrence in GC patient.
Conclusions
Taking together, we have been the first to provide a sys-
tematic analysis for comprehensive gene expression profile
integrated with microRNA , genomic or proteomic analy-
sis for gastric cancer. Additionally, we have defined a
group of genes associated with development and prognosis
in gastric cancer.
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